EMJ GOLD - European Medical Journal

This site is intended for healthcare professionals

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
desktop showing data

Pharma to FDA: upgrade cell and gene data sharing

The pharmaceutical industry is calling on the FDA to modernise how it tracks the long-term safety and efficacy of cell and gene therapies.
Two people making a handshake

J&J acquires Halda to take on cancer cell resistance

J&J successfully acquired Halda Therapeutics for $3.05bn integrating Halda’s RIPTAC platform into J&J’s oncology portfolio.
Pharma R&D cycle

End of lifelong pills? GSK’s phase 3 success in hepatitis B

GSK announced in January that its novel chronic hepatitis B successfully met primary goals in two pivotal phase 3 trials.
Vaccine administration

US slashes vaccine schedule: a major shift for paediatrics

CDC has formally reduced its routine childhood vaccine recommendations from 17 to 11, marking a major shift in US healthcare, read more.
Two US flags on beige background

Nine pharma giants sign on to Trump pricing deal

President Donald Trump has unveiled a new set of sweeping pricing deals with nine large drugmakers, according to a White House press release.
Handshake on blue background

GSK signs $17.5m RNA therapeutics pact with CAMP4

GSK has struck the collaboration to accelerate development of RNA-based therapies for neurodegenerative and renal disorders.
Door with light pouring out of it

NICE appoints Prof Jonathan Benger as new CEO

His appointment comes at a pivotal moment for the organisation, as NICE prepares to help deliver the 10 Year Health Plan for the NHS.
Gold coins on blue background

VPAG 2026 rate set at 14.5%, post US tariff deal

Industry leaders cautiously welcome the step but warn that more reform is needed if the UK is to regain its competitive edge.
We’ve noticed you’re accessing
from North/South America.